Worldwide Medtech vs. Prescription Drug Sales (2009-2022)
October 6, 2017
Source: evaluategroup
1,093
Worldwide prescription drug market only forecast to grow at a marginally faster rate than the medtech market. Evaluate consensus forecasts find that the worldwide market for prescription drugs is set to narrowly outperform the medical device market with a 5.2% market growth per year between 2016 and 2022, versus a 5.1% growth rate per year for medical devices.
Overall, in 2022, the medtech industry will be 50.0% of the size of the prescription drug market, not showing much variation from 2016. Both industries returned to growth in dollar terms in 2016 after contracting in 2015 as a result of the weakness in the Euro, as US companies recognised fewer dollars for sales in the Eurozone.
CAGR 2016-22
WW Medtech Sales +5.1%
WW Prescription Drug Sales +5.2%
Note: Prescription drug sales based on top 500 pharmaceutical and biotech companies from EvaluatePharma®. Sales to 2016 based on company reported sales data. Sales forecasts to 2022 based on a consensus of leading equity analysts’ estimates for segmental sales.
By Ddu
Copyright©2024 Ddu. All rights reserved.
Read more on
- China’s Import and Export Market Report of Vitamins August 26, 2021
- China’s Import and Export Market Report of Rheumatoid Arthritis Drugs August 26, 2021
- What’s Driving the Global Surgical Robotics Market February 26, 2018
- Ddu College–China’s Import and Export Market Report of Antiallergic Drugs December 1, 2017
- Brief Report on Exports of Chinese Vaccines in the First Three Quarters of 2017 November 27, 2017
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
